Veru (STU:FMW) Interest Expense : €-1.08 Mil (TTM As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Veru Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Veru's interest expense for the three months ended in Mar. 2024 was € -0.13 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was €-1.08 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Veru's Operating Income for the three months ended in Mar. 2024 was € -9.10 Mil. Veru's Interest Expense for the three months ended in Mar. 2024 was € -0.13 Mil. Veru did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Veru Interest Expense Historical Data

The historical data trend for Veru's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Veru Interest Expense Chart

Veru Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Interest Expense

Get a 7-Day Free Trial

-4.27

-3.86

-4.12

-4.41

-2.27

Veru Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-0.65	-0.60	-0.19	-0.15	-0.13

Veru Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.08 Mil.

Veru (STU:FMW) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Veru's Interest Expense for the three months ended in Mar. 2024 was €-0.13 Mil. Its Operating Income for the three months ended in Mar. 2024 was €-9.10 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was €11.08 Mil.

Veru's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Veru did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Veru (STU:FMW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Veru Inc (STU:FMW) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

VERU:USA FMW:Germany

Address

2916 North Miami Avenue, Suite 1000, Miami, FL, USA, 33127

Website

https://www.verupharma.com

Veru Inc is a biopharmaceutical company with a drug development program for the treatment of metabolic diseases, oncology and acute respiratory distress syndrome (ARDS). The company is also in the late stage development of certain drugs for management of breast and prostate cancers. It also has a sexual health program which includes two products, ENTADFI, for the treatment of benign prostatic hyperplasia (BPH) and the FC2 Female Condom (Internal Condom). The company operates in single segment and generates revenue from USA which is the key revenue generating market, South Africa and other regions.

Veru (STU:FMW) Headlines

No Headlines